INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 177 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $389,000 | -21.9% | 8,357 | -4.1% | 0.15% | -39.4% |
| Q2 2022 | $498,000 | +78.5% | 8,716 | -19.9% | 0.25% | -64.4% |
| Q3 2020 | $279,000 | +27.4% | 10,882 | +7.6% | 0.70% | +636.8% |
| Q3 2018 | $219,000 | -58.9% | 10,109 | -66.5% | 0.10% | -43.8% |
| Q2 2018 | $533,000 | +38.1% | 30,162 | +13.3% | 0.17% | +49.6% |
| Q4 2017 | $386,000 | -1.0% | 26,625 | +7.8% | 0.11% | +2.7% |
| Q3 2017 | $390,000 | +68.8% | 24,700 | +61.4% | 0.11% | -9.1% |
| Q4 2016 | $231,000 | -27.4% | 15,300 | +86.6% | 0.12% | -21.4% |
| Q2 2016 | $318,000 | – | 8,200 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |